Literature DB >> 3422343

Localized production of TGF-beta mRNA in tumour promoter-stimulated mouse epidermis.

R J Akhurst1, F Fee, A Balmain.   

Abstract

Tumour promoters induce a wide spectrum of morphological and biochemical alterations when applied to mouse epidermis in vivo. These include the induction of RNA, DNA and protein synthesis during discrete phases of proliferation and differentiation. This constitutes an ideal model for studying molecular events underlying the disruption of epidermal homeostasis by TPA, and its subsequent re-establishment. Transforming growth factor-beta (TGF-beta) can induce either growth stimulation, inhibition, or differentiation, depending on the target cell. A function has been proposed for TGF-beta in wound healing and in tumour promotion, but the main source of TGF-beta is generally thought to be platelets, macrophages or lymphocytes, and a direct role for this growth factor in regulating tissue homeostasis in vivo has not been demonstrated. We show here that when the tumour promoter 12-tetradecanoyl-phorbol-13-acetate (TPA) is applied to the skin of mice, very high levels of TGF-beta messenger RNA are induced in the epidermal cells. In situ hybridization techniques show that the main site of TGF-beta synthesis is in the suprabasal differentiating epidermal cells. These results suggest that TGF-beta may be a natural regulator of epidermal homeostasis which is important in tumour promotion.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422343     DOI: 10.1038/331363a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  61 in total

1.  A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells.

Authors:  R E Wager; R K Assoian
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  TGF-beta does not appear to mediate all effects of 12-O-tetradecanoylphorbol-13-acetate on the anchorage-independent growth of murine epithelial JB6 cells.

Authors:  P J Wilder; A Rizzino
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

Review 3.  Growth inhibitors: molecular diversity and roles in cell proliferation.

Authors:  K Miyazaki; T Horio
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

Review 4.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

5.  Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis.

Authors:  Rolando Pérez-Lorenzo; Lauren Mordasky Markell; Kelly A Hogan; Stuart H Yuspa; Adam B Glick
Journal:  Carcinogenesis       Date:  2010-02-19       Impact factor: 4.944

Review 6.  Transforming growth factor-beta in disease: the dark side of tissue repair.

Authors:  W A Border; E Ruoslahti
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

7.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Authors:  G H Gibbons; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

8.  Isolation and characterization of a variant myoblast cell line that is temperature sensitive for differentiation.

Authors:  R J Akhurst; N B Flavin; J Worden
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

9.  Loss of expression of transforming growth factor beta in skin and skin tumors is associated with hyperproliferation and a high risk for malignant conversion.

Authors:  A B Glick; A B Kulkarni; T Tennenbaum; H Hennings; K C Flanders; M O'Reilly; M B Sporn; S Karlsson; S H Yuspa
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

10.  Retinoic acid induces transforming growth factor-beta 2 in cultured keratinocytes and mouse epidermis.

Authors:  A B Glick; K C Flanders; D Danielpour; S H Yuspa; M B Sporn
Journal:  Cell Regul       Date:  1989-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.